E
Scryb Inc.
SCYB
CNSX
E
Sell
5/30/2023Downgrade
Scryb Inc. (SCYB) was downgraded to E+ from D- on 5/30/2023 due to a decline in the total return index and volatility index.
Scryb Inc. (SCYB) was downgraded to E+ from D- on 5/30/2023 due to a decline in the total return index and volatility index.
D
Sell
3/6/2023Downgrade
Scryb Inc. (SCYB) was downgraded to D- from D on 3/6/2023 due to a significant decline in the growth index and solvency index. Operating cash flow declined 724.14% from $872.5 to -$5.45M, EBIT declined 209.77% from -$2.04M to -$6.33M, and earnings per share declined from -$0.0095 to -$0.0265.
Scryb Inc. (SCYB) was downgraded to D- from D on 3/6/2023 due to a significant decline in the growth index and solvency index. Operating cash flow declined 724.14% from $872.5 to -$5.45M, EBIT declined 209.77% from -$2.04M to -$6.33M, and earnings per share declined from -$0.0095 to -$0.0265.
D
Sell
2/1/2023Upgraded
Scryb Inc. (SCYB) was upgraded to D from D- on 2/1/2023 due to a significant increase in the growth index, volatility index and total return index. Total revenue increased 533.6% from $49.7 to $314.9, operating cash flow increased 151.7% from -$1.69M to $872.5, and earnings per share increased from -$0.0139 to -$0.0095.
Scryb Inc. (SCYB) was upgraded to D from D- on 2/1/2023 due to a significant increase in the growth index, volatility index and total return index. Total revenue increased 533.6% from $49.7 to $314.9, operating cash flow increased 151.7% from -$1.69M to $872.5, and earnings per share increased from -$0.0139 to -$0.0095.
D
Sell
1/4/2023Upgraded
Scryb Inc. (SCYB) was upgraded to D- from E+ on 1/4/2023 due to an increase in the valuation index and total return index.
Scryb Inc. (SCYB) was upgraded to D- from E+ on 1/4/2023 due to an increase in the valuation index and total return index.
E
Sell
12/19/2022Downgrade
Scryb Inc. (SCYB) was downgraded to E+ from D- on 12/19/2022 due to a decline in the valuation index.
Scryb Inc. (SCYB) was downgraded to E+ from D- on 12/19/2022 due to a decline in the valuation index.
D
Sell
11/9/2022Upgraded
Scryb Inc. (SCYB) was upgraded to D- from E+ on 11/9/2022 due to an increase in the volatility index.
Scryb Inc. (SCYB) was upgraded to D- from E+ on 11/9/2022 due to an increase in the volatility index.
E
Sell
9/2/2022Downgrade
Scryb Inc. (SCYB) was downgraded to E+ from D- on 9/2/2022 due to a major decline in the solvency index, volatility index and growth index. Operating cash flow declined 175.24% from -$613.4 to -$1.69M, EBIT declined 72.08% from -$1.57M to -$2.7M, and the quick ratio declined from 3.84 to 1.15.
Scryb Inc. (SCYB) was downgraded to E+ from D- on 9/2/2022 due to a major decline in the solvency index, volatility index and growth index. Operating cash flow declined 175.24% from -$613.4 to -$1.69M, EBIT declined 72.08% from -$1.57M to -$2.7M, and the quick ratio declined from 3.84 to 1.15.
D
Sell
6/9/2022Downgrade
Scryb Inc. (SCYB) was downgraded to D- from D on 6/9/2022 due to a decline in the volatility index, valuation index and growth index. Earnings per share declined from -$0.0042 to -$0.0113, and EBIT declined 9.06% from -$1.46M to -$1.59M.
Scryb Inc. (SCYB) was downgraded to D- from D on 6/9/2022 due to a decline in the volatility index, valuation index and growth index. Earnings per share declined from -$0.0042 to -$0.0113, and EBIT declined 9.06% from -$1.46M to -$1.59M.
D
Sell
5/5/2022Upgraded
Scryb Inc. (SCYB) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and volatility index.
Scryb Inc. (SCYB) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and volatility index.
D
Sell
4/20/2022Downgrade
Scryb Inc. (SCYB) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, growth index and valuation index. Total revenue declined 91.19% from $582.5 to $51.3.
Scryb Inc. (SCYB) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, growth index and valuation index. Total revenue declined 91.19% from $582.5 to $51.3.
D
Sell
11/23/2021Upgraded
Relay Medical Corp. (RELA) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Relay Medical Corp. (RELA) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Scryb Inc. (SCYB) was downgraded to D- from D on 11/08/2021.
Scryb Inc. (SCYB) was downgraded to D- from D on 11/08/2021.
D
Sell
9/1/2021Upgraded
Relay Medical Corp. (RELA) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0339 to $0.0024, operating cash flow increased 69.02% from -$3.05M to -$946, and EBIT increased 60.51% from -$4.8M to -$1.9M.
Relay Medical Corp. (RELA) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0339 to $0.0024, operating cash flow increased 69.02% from -$3.05M to -$946, and EBIT increased 60.51% from -$4.8M to -$1.9M.
D
Sell
8/30/2021Downgrade
Relay Medical Corp. (RELA) was downgraded to D- from D on 8/30/2021 due to a large decline in the growth index and volatility index. Operating cash flow declined 249.22% from -$874.4 to -$3.05M, EBIT declined 225.53% from -$1.47M to -$4.8M, and earnings per share declined from -$0.0122 to -$0.0339.
Relay Medical Corp. (RELA) was downgraded to D- from D on 8/30/2021 due to a large decline in the growth index and volatility index. Operating cash flow declined 249.22% from -$874.4 to -$3.05M, EBIT declined 225.53% from -$1.47M to -$4.8M, and earnings per share declined from -$0.0122 to -$0.0339.
D
Sell
9/2/2020Upgraded
Relay Medical Corp. (RELA) was upgraded to D from D- on 9/2/2020 due to a large increase in the growth index. EBIT increased 57.59% from -$2.18M to -$922.5, and earnings per share increased from -$0.0184 to -$0.0081.
Relay Medical Corp. (RELA) was upgraded to D from D- on 9/2/2020 due to a large increase in the growth index. EBIT increased 57.59% from -$2.18M to -$922.5, and earnings per share increased from -$0.0184 to -$0.0081.
D
Sell
6/2/2020Downgrade
Relay Medical Corp. (RELA) was downgraded to D- from D on 6/2/2020 due to a substantial decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.16 to 2.11, earnings per share declined from -$0.0046 to -$0.0184, and EBIT declined 242.61% from -$634.9 to -$2.18M.
Relay Medical Corp. (RELA) was downgraded to D- from D on 6/2/2020 due to a substantial decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.16 to 2.11, earnings per share declined from -$0.0046 to -$0.0184, and EBIT declined 242.61% from -$634.9 to -$2.18M.
D
Sell
5/1/2020Upgraded
Relay Medical Corp. (RELA) was upgraded to D from D- on 5/1/2020 due to a noticeable increase in the volatility index and total return index.
Relay Medical Corp. (RELA) was upgraded to D from D- on 5/1/2020 due to a noticeable increase in the volatility index and total return index.
D
Sell
7/1/2016Upgraded
ChroMedX Corp. (CHX) was upgraded to D- from E on 7/1/2016 due to an increase in the growth index, total return index and solvency index. The quick ratio increased from 4.73 to 9.09.
ChroMedX Corp. (CHX) was upgraded to D- from E on 7/1/2016 due to an increase in the growth index, total return index and solvency index. The quick ratio increased from 4.73 to 9.09.
E
Sell
4/1/2016Upgraded
ChroMedX Corp. (CHX) was upgraded to E from E- on 4/1/2016 due to an increase in the valuation index.
ChroMedX Corp. (CHX) was upgraded to E from E- on 4/1/2016 due to an increase in the valuation index.
E
Sell
3/11/2016Downgrade
ChroMedX Corp. (CHX) was downgraded to E- from E on 3/11/2016 due to a large decline in the volatility index and efficiency index. Total capital declined 1.84% from $2.46M to $2.41M.
ChroMedX Corp. (CHX) was downgraded to E- from E on 3/11/2016 due to a large decline in the volatility index and efficiency index. Total capital declined 1.84% from $2.46M to $2.41M.
E
Sell
1/20/2016None
Scryb Inc. (SCYB) was downgraded to E from U on 01/20/2016.
Scryb Inc. (SCYB) was downgraded to E from U on 01/20/2016.